<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04866628</url>
  </required_header>
  <id_info>
    <org_study_id>SMILJ_Clinical</org_study_id>
    <nct_id>NCT04866628</nct_id>
  </id_info>
  <brief_title>Clinical Trials of Two Helichrysum Infusions in Adults</brief_title>
  <acronym>SMILJ</acronym>
  <official_title>Comparison of Helichrysum Italicum Infusion and Helichrysum Arenarium Infusion Effects on the Components of Metabolic Syndrome in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Primorska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Primorska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the effects of Helichrysum italicum and Helichrysum Arenarium on&#xD;
      different components of the metabolic syndrome. The components of metabolic syndrome will be&#xD;
      measured at baseline and four weeks after daily consumptions of either Helichrysum italicum&#xD;
      or either Helichrysum Arenarium, and after two weeks of washout. In addition, stool samples&#xD;
      will be also taken at baseline and after four weeks of daily consumtion of either Helichrysum&#xD;
      italicum or either Helichrysum Arenarium.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Helichrysum arenarium (HA) has a long tradition in European ethno-medicine as a medicinal&#xD;
      plant with many known activities; EU monograph supports its use for the digestive disorders,&#xD;
      feeling of fullness and bloating, and, importantly, it re-ports no side effects. Assessment&#xD;
      report of the European Medicines Agency Committee on Herbal Medicinal Products supports its&#xD;
      stimulatory role in the bile flow and in the release of cholesterol to the bile. HA has also&#xD;
      been used in chronic liver inflammatory disease and as a scavenger of free radicals. Similar&#xD;
      to HA Helichrysum italicum (HI) is widely used in traditional medicine. Lately, much&#xD;
      attention has been given to natural antioxidants and their ability to delay the progression&#xD;
      of chronic diseases related to the formation and the activity of reactive oxygen species and&#xD;
      other free radicals. Herbs are very often used to prepare recreational tea and are thereby&#xD;
      important sources of antioxidants in different cultures. In traditional medicine, HI is also&#xD;
      used in diet, mainly for the preparation of infusions in treating respiratory and digestive&#xD;
      conditions.&#xD;
&#xD;
      Therefore,the ail of our study is to evaluate the effects of Helichrysum italicum and&#xD;
      Helichrysum Arenarium on different components of the metabolic syndrome in adults presenting&#xD;
      at least two components of metabolic syndrome and yet not receiving any medication. The&#xD;
      components of metabolic syndrome (lipid profile, blood pressure, antrophometry, inflammation&#xD;
      status, glucose levels) will be measured at baseline and four weeks after daily consumptions&#xD;
      of either Helichrysum italicum or either Helichrysum Arenarium, and after two weeks of&#xD;
      washout. In addition, stool samples will be also taken at baseline and after four weeks of&#xD;
      daily consumtion of either Helichrysum italicum or either Helichrysum Arenarium.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 6, 2021</start_date>
  <completion_date type="Actual">June 19, 2021</completion_date>
  <primary_completion_date type="Actual">June 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>changes from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Changes in total cholesterol, LDL cholesterol, HDL cholesterol and triacylglycerides will be examined with biochemical analyzer Cobass</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>changes from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Systolic and diastolic blood pressure will be determined with blood pressure device (Omron M3)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>Chages from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Changes in C-reactive protein levels will be examined with biochemical analyzer Cobass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements</measure>
    <time_frame>Chages from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Changes in body weight (in kilograms) will be examined with bioelectrical impedance analysis (BIA) Tanita MC-980MA (Maeno-cho, Japan) and dedicated software (GMON Pro-Tanita).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiota</measure>
    <time_frame>Chages from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>The microbiota composition will be determined with gene sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antioxidative potential</measure>
    <time_frame>Chages from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Antioxidative potential will be determined with DPPH radical measuremen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements</measure>
    <time_frame>Chages from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Changes in visceral fat rating will be examined with bioelectrical impedance analysis (BIA) Tanita MC-980MA (Maeno-cho, Japan) and dedicated software (GMON Pro-Tanita).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements Description:</measure>
    <time_frame>Chages from baseline to four weeks of daily consumption and after two weeks of washout</time_frame>
    <description>Changes in fat (percentage of body fat) will be examined with bioelectrical impedance analysis (BIA) Tanita MC-980MA (Maeno-cho, Japan) and dedicated software (GMON Pro-Tanita).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hypertension</condition>
  <condition>Hyperlipidemias</condition>
  <condition>Inflammation</condition>
  <condition>Hyperglycemia</condition>
  <condition>Hypercholesterolemia</condition>
  <condition>Microbial Colonization</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Helichrysum italicum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 g of milled plant material (Helichrysum italicum) immersed in hot water (200 mL, 100 °C) for 10minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Helichrysum arenarium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 g of milled plant material (Helichrysum arenarium) immersed in hot water (200 mL, 100 °C) for 10minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Helichrysum italicum infusion</intervention_name>
    <description>Comparison of metabolic syndrome components before and after four weeks of daily consumption of Helichrysum italicum infusion.</description>
    <arm_group_label>Helichrysum italicum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Helichrysum arenarium</intervention_name>
    <description>Comparison of metabolic syndrome components before and after four weeks of daily consumption of Helichrysum arenarium infusion.</description>
    <arm_group_label>Helichrysum arenarium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  stable weight in the last 3 months&#xD;
&#xD;
          -  BMI more than 25&#xD;
&#xD;
          -  clinical diagnosis of at least two components of metabolic syndrome,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  consumption of dietary supplements&#xD;
&#xD;
          -  medications for any component of metabolic syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Primorska, Faculty of Health Sciences</name>
      <address>
        <city>Izola</city>
        <zip>6310</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <reference>
    <citation>Pljevljakušić D, Bigović D, Janković T, Jelačić S, Šavikin K. Sandy Everlasting (Helichrysum arenarium (L.) Moench): Botanical, Chemical and Biological Properties. Front Plant Sci. 2018 Aug 7;9:1123. doi: 10.3389/fpls.2018.01123. eCollection 2018. Review.</citation>
    <PMID>30131818</PMID>
  </reference>
  <reference>
    <citation>Sala A, Recio M, Giner RM, Máñez S, Tournier H, Schinella G, Ríos JL. Anti-inflammatory and antioxidant properties of Helichrysum italicum. J Pharm Pharmacol. 2002 Mar;54(3):365-71.</citation>
    <PMID>11902802</PMID>
  </reference>
  <reference>
    <citation>Kramberger K, Jenko Pražnikar Z, Baruca Arbeiter A, Petelin A, Bandelj D, Kenig S. A Comparative Study of the Antioxidative Effects of Helichrysum italicum and Helichrysum arenarium Infusions. Antioxidants (Basel). 2021 Mar 3;10(3). pii: 380. doi: 10.3390/antiox10030380.</citation>
    <PMID>33802628</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 23, 2021</study_first_submitted>
  <study_first_submitted_qc>April 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Primorska</investigator_affiliation>
    <investigator_full_name>Zala Jenko Praznikar</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>metabolic syndrome</keyword>
  <keyword>herbal infusions</keyword>
  <keyword>diet</keyword>
  <keyword>microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

